Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Current Assets: 2015-2025

Historic Current Assets for Editas Medicine (EDIT) over the last 10 years, with Sep 2025 value amounting to $176.9 million.

  • Editas Medicine's Current Assets fell 34.76% to $176.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $176.9 million, marking a year-over-year decrease of 34.76%. This contributed to the annual value of $289.3 million for FY2024, which is 15.11% down from last year.
  • As of Q3 2025, Editas Medicine's Current Assets stood at $176.9 million, which was down 3.23% from $182.8 million recorded in Q2 2025.
  • In the past 5 years, Editas Medicine's Current Assets ranged from a high of $632.3 million in Q1 2021 and a low of $176.9 million during Q3 2025.
  • Its 3-year average for Current Assets is $291.1 million, with a median of $289.3 million in 2024.
  • As far as peak fluctuations go, Editas Medicine's Current Assets soared by 48.74% in 2021, and later crashed by 36.16% in 2025.
  • Over the past 5 years, Editas Medicine's Current Assets (Quarterly) stood at $507.3 million in 2021, then decreased by 29.68% to $356.8 million in 2022, then declined by 4.46% to $340.8 million in 2023, then decreased by 15.11% to $289.3 million in 2024, then tumbled by 34.76% to $176.9 million in 2025.
  • Its Current Assets was $176.9 million in Q3 2025, compared to $182.8 million in Q2 2025 and $224.8 million in Q1 2025.